skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin

Review

(2850) Views  (603) Full article downloads

Authors: Bilal Chughtai, Robert Levin, Elise De

Published Date October 2008 Volume 2008:3(3) Pages 503 - 509
DOI: http://dx.doi.org/10.2147/CIA.S3414

Bilal Chughtai1, Robert Levin2, Elise De1

1Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USA

Abstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe community. OAB affects 16% of the adult population and rises with increasing age. We describe the necessary steps in evaluation and behavioral therapy prior to initiating medical therapy. There are several medications that have been used for the treatment of patients who suffer from OAB. This manuscript discusses the popular agents used for OAB, with a focus on the recent clinical trials on darifenacin.

Keywords: darifenacin, overactive bladder, urge incontinence, older patients, aging








Readers of this article also read:

Pharmacologic management of overactive bladder
Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
Study of the intima-media thickening in carotid arteries of healthy elderly with high blood pressure and elderly with high blood pressure and dyslipidemia
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
Fesoterodine for the treatment of urinary incontinence and overactive bladder
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Erratum